Xcout Intel
Pelage Pharmaceuticals, Inc.
Pelage Pharmaceuticals, Inc. is a regenerative medicine biotechnology company. It focuses on developing innovative treatments for hair loss.
Subscribe to see Pelage Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pelage Pharmaceuticals, Inc. at a glance
Pelage Pharmaceuticals, Inc. is a company headquartered in United States. It has raised at least $150.7M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $120M in October 2025. Xcout tracks 15 named people at Pelage Pharmaceuticals, Inc., including Daniel Gil (Chief Executive Officer).
Pelage Pharmaceuticals, Inc. leadership
- Daniel GilChief Executive Officer
- Qing Yu Christina WengChief Medical Officer
- William LowryCo-Founder and President
- Heather ChristofkCo-Founder
- Michael JungCo-Founder
- Christina Edward WengExecutive Officer
9 more named people on record for Pelage Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Pelage Pharmaceuticals, Inc. funding rounds
At least $150.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $120M | 5 named | |
| SEC Form D filing | $14M | — | |
| SEC Form D filing | $16.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Pelage Pharmaceuticals, Inc. competitors
A few of Pelage Pharmaceuticals, Inc.'s closest competitors — see the full list of competitors and alternatives →
Histogen Inc. is a biotechnology company headquartered in San Diego, California, focused on the development of regenerative medicine and novel therapeutics.
NuGene International, Inc. is a beauty, personal care, and regenerative biotechnology company based in Irvine, United States. The publicly traded company develops and offers consumer care items such as the NuGene Regenerative Shampoo.
Humabiologics, Inc. is a regenerative medicine company that provides human-derived biomaterials such as collagen and gelatin for research and therapeutic applications.
dNovo is a Silicon Valley-based startup focused on solving the aging problem by developing a potential cure for hair loss through direct reprogramming technology to generate personalized hair stem cells. The company aims to transform regenerative medicine by creating new stem cells from sources like skin and blood.
Platelet BioGenesis, Inc. is a biotechnology leader headquartered in Cambridge, Massachusetts, focused on producing stem cell-derived, on-demand human platelets. The company develops innovative biomedical solutions for therapeutic applications.
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
Get Pelage Pharmaceuticals, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pelage Pharmaceuticals, Inc. in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access